Article contents
Comment from the CDC
Published online by Cambridge University Press: 02 January 2015
Extract
Dr. Glatt makes some thoughtful observations, and his recommendations are similar in many respects to those developed by the Public Health Service (PHS) with advice from expert consultants. However, the PHS did not recommend that new antiretroviral drugs be used routinely to treat lower-risk exposures, because relatively limited data are available on the safety and tolerability of the newer drugs and because the overwhelming majority of workers with lower-risk exposures will not become infected. (The average risk of human immunodeficiency virus [HIV] transmission is 0.3% after a percutaneous exposure to HIV-infected blood and less than that for a mucous membrane or skin exposure.)
- Type
- Readers' Forum
- Information
- Copyright
- Copyright © The Society for Healthcare Epidemiology of America 1996
References
- 2
- Cited by